Zebra Medical Vision (Nanox)
Integrations
- Nanox.ARC X
- PACS / VNA
- HL7 FHIR
- 3DR Labs
- Nanox.CLOUD
Pricing Details
- Commercial deployments in 2026 focus on annual SaaS subscriptions.
- Pricing tiers are scaled based on hospital volume and the activation of specific modules within the Nanox.CLOUD.
Features
- Nanox.ARC X Hardware-AI Integration
- HealthBox Opportunistic Screening Suite
- Aortic Valve & Body Composition Modules
- Nanox.CLOUD SaaS Orchestration
- 3DR Labs Reseller Integration
- HL7 FHIR & DICOM Interoperability
Description
Nanox.AI System Architecture Assessment
As of January 2026, Nanox.AI (the software arm of Nano-X Imaging) has transitioned from a standalone algorithm suite to an integrated hardware-software ecosystem. The architecture is centered on Nanox.CLOUD, which orchestrates data flows from traditional CT scanners and the newly FDA-cleared Nanox.ARC X digital tomosynthesis system 📑. This shift allows for advanced 3D imaging in everyday care settings at a significantly lower cost and radiation dose than conventional CT 📑.
Imaging Orchestration & Analysis Pipeline
The system utilizes a containerized processing engine to execute FDA-cleared algorithms, now including specialized tools for aortic valve and body composition analysis.
- Nanox.ARC X Integration: Direct ingestion of digital tomosynthesis data, providing 3D-like views with simplified 'plug and play' installation in shielded rooms 📑.
- HealthBox Suite (2026): Orchestrates modules including HealthCCSng (Cardiac), HealthOST (Bone), and HealthFLD (Liver), supplemented by new pulmonary nodule detection algorithms 📑.
- Strategic Reseller Network: Integration with 3DR Labs infrastructure, allowing for rapid scaling of AI-driven post-processing across US hospital networks 📑.
⠠⠉⠗⠑⠁⠞⠑⠙⠀⠃⠽⠀⠠⠁⠊⠞⠕⠉⠕⠗⠑⠲⠉⠕⠍
Operational Scenarios
- Advanced Cardiac Screening: Input: Routine chest tomosynthesis (DICOM) via Nanox.ARC X → Process: Automatic aortic valve calcification measurement and CAC scoring via HealthCCSng → Output: Agatston-equivalent score populated in the radiology worklist 📑.
- Population Health Bone Analysis: Input: Existing CT archives or new lumbar X-rays → Process: HealthOST algorithm identifies vertebral fractures and low bone mineral density (BMD) markers → Output: Automated notification to population health managers for osteoporosis intervention 📑.
Evaluation Guidance
Technical evaluators should verify the following architectural characteristics:
- ARC X Latency: Benchmark the reconstruction and AI analysis time for Nanox.ARC X digital tomosynthesis data compared to standard CT cloud processing 🧠.
- 3DR Labs Workflow Integration: Verify the hand-off protocol between 3DR Labs' remote reading services and the Nanox.AI automated reporting module 🌑.
- FHIR R5 Compatibility: Organizations should validate the depth of bidirectional data sync for AI findings within the latest Epic/Cerner EHR modules for 2026 🌑.
Release History
Year-end update: Launch of the Autonomous Screening Hub. Real-time integration with Nanox.ARC sources to flag 'silent killers' during initial scan acquisition.
Integration of Generative AI for automated report drafting. AI findings are now contextually translated into standardized clinical narratives for specialists.
Enhanced cardiac suite. New algorithms for Epicardial Adipose Tissue (EAT) measurement and thoracic aortic aneurysm detection.
Launch of HealthBox. A population health tool that automatically identifies patients with undiagnosed osteoporosis and heart disease from existing CT archives.
Zebra Medical Vision was acquired by Nanox for $200M. Rebranded as Nanox.AI to integrate software with the Nanox.ARC imaging hardware.
Launch of a comprehensive AI suite for health providers. Focused on high-volume screening for vertebral fractures and emphysema.
Received first FDA clearance for automated Coronary Artery Calcium (CAC) scoring from CT scans. Enabled early cardiovascular risk detection.
Official launch of the platform. Introduced the 1$/scan model to democratize AI in radiology. Initial focus on bone health and liver fat analysis.
Tool Pros and Cons
Pros
- Faster, accurate diagnoses
- Quantitative image insights
- Reduced radiologist workload
- Early disease detection
- Improved patient outcomes
- Workflow efficiency
- Clinical decision support
Cons
- Large datasets required
- Regulatory approvals pending
- Complex integration